You are here: Home » PTI Stories » National » News
Business Standard

Abbott India Q4 net dips 29 pc to Rs 42 cr

Press Trust of India  |  New Delhi 

Pharma firm today reported a 28.69 per cent plunge in standalone net profit to Rs 42.06 crore for the fourth quarter ended March 31, 2017.

The company had posted a net profit of Rs 58.99 crore for the corresponding period of the previous fiscal, said in a filing to



Total for the quarter under consideration, however, rose to Rs 730.87 crore as against Rs 702.39 crore for the same period a year ago.

For the fiscal ended March this year the net profit stood at Rs 276.65 crore, compared to Rs 255.25 crore a year ago.

Total of the company for the fiscal year ended March 2017 was Rs 2,996.33 crore as against Rs 2,696.23 crore in the previous fiscal year.

In a separate filing, the company said its board has recommended a final dividend of Rs 40 per equity share.

of today closed at Rs 4,194.95 per scrip on BSE, down 0.24 per cent from its previous close.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Abbott India Q4 net dips 29 pc to Rs 42 cr

Pharma firm Abbott India today reported a 28.69 per cent plunge in standalone net profit to Rs 42.06 crore for the fourth quarter ended March 31, 2017. The company had posted a net profit of Rs 58.99 crore for the corresponding period of the previous fiscal, Abbott India said in a filing to BSE. Total income for the quarter under consideration, however, rose to Rs 730.87 crore as against Rs 702.39 crore for the same period a year ago. For the fiscal ended March this year the net profit stood at Rs 276.65 crore, compared to Rs 255.25 crore a year ago. Total income of the company for the fiscal year ended March 2017 was Rs 2,996.33 crore as against Rs 2,696.23 crore in the previous fiscal year. In a separate filing, the company said its board has recommended a final dividend of Rs 40 per equity share. Shares of Abbott India today closed at Rs 4,194.95 per scrip on BSE, down 0.24 per cent from its previous close. Pharma firm today reported a 28.69 per cent plunge in standalone net profit to Rs 42.06 crore for the fourth quarter ended March 31, 2017.

The company had posted a net profit of Rs 58.99 crore for the corresponding period of the previous fiscal, said in a filing to

Total for the quarter under consideration, however, rose to Rs 730.87 crore as against Rs 702.39 crore for the same period a year ago.

For the fiscal ended March this year the net profit stood at Rs 276.65 crore, compared to Rs 255.25 crore a year ago.

Total of the company for the fiscal year ended March 2017 was Rs 2,996.33 crore as against Rs 2,696.23 crore in the previous fiscal year.

In a separate filing, the company said its board has recommended a final dividend of Rs 40 per equity share.

of today closed at Rs 4,194.95 per scrip on BSE, down 0.24 per cent from its previous close.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Abbott India Q4 net dips 29 pc to Rs 42 cr

Pharma firm today reported a 28.69 per cent plunge in standalone net profit to Rs 42.06 crore for the fourth quarter ended March 31, 2017.

The company had posted a net profit of Rs 58.99 crore for the corresponding period of the previous fiscal, said in a filing to

Total for the quarter under consideration, however, rose to Rs 730.87 crore as against Rs 702.39 crore for the same period a year ago.

For the fiscal ended March this year the net profit stood at Rs 276.65 crore, compared to Rs 255.25 crore a year ago.

Total of the company for the fiscal year ended March 2017 was Rs 2,996.33 crore as against Rs 2,696.23 crore in the previous fiscal year.

In a separate filing, the company said its board has recommended a final dividend of Rs 40 per equity share.

of today closed at Rs 4,194.95 per scrip on BSE, down 0.24 per cent from its previous close.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22